Ligand Pharmaceuticals Inc (LGND)

Total Costs & Expenses

$189.61M

TTM · Period ending: · USD

LGND logo

LGND Total Costs & Expenses

Latest reported$189.61M
LGND TTM Total Costs & Expenses ($34.20M → $189.61M)
High-resolution chart · PNG

LGND total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
189,612,000
173,693,000
220,888,000
233,711,000
221,850,000
243,298,000
189,739,000
168,749,000
149,870,000
117,588,000
119,372,000
102,782,000
119,872,000
132,987,000
137,596,000
182,466,000
184,715,000
182,187,000
198,239,000
197,280,000
186,252,000
181,636,000
160,574,000
138,976,000
130,841,000
125,638,000
126,003,000
115,262,000
107,597,000
98,348,000
87,726,000
83,399,000
77,980,000
73,092,000
73,027,000
69,575,000
68,601,000
68,392,000
63,649,000
54,929,000
47,780,000
46,844,000
43,566,000
46,424,000
48,924,000
44,203,000
43,827,000
39,137,000
37,586,000
36,014,000
32,990,000
33,967,000
31,971,000
31,654,000
30,499,000
30,344,000
29,490,000
30,980,000
31,196,000
31,114,000
47,733,000
48,484,000
52,203,000
56,500,000
60,594,000
63,429,000
70,298,000
70,929,000
54,961,000
53,097,000
52,591,000
52,625,000
55,225,000
60,564,000
73,069,000
88,493,000
126,062,000
169,723,000
328,502,000
349,013,000
343,340,000
336,209,000
200,907,000
200,058,000
207,341,000
206,760,000
200,883,000
198,943,000
185,038,000
171,509,000
160,317,000
146,224,000
138,800,000
129,245,000
120,792,000
113,117,000
104,797,000
101,310,000
99,478,000
97,534,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.